Healthcare / Health Information ServicesLSE
$7.70
-0.40 (-4.94%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-3.5M · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
10/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-118.7%
↓Gross Margin
87.9%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+14.6%
FCF CAGR
—
FCF margin
-412.7%
FCF / Net income
0.50x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $885623.0 · net income $-7.3M · FCF $-3.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $885623.00 | $885623.00 | $1.2M | $1.0M | $588576.00 |
| Net Income | $-7.3M | $-7.3M | $-3.3M | $-2.9M | $-2.1M |
| EBITDA | $-3.1M | $-3.1M | $-2.7M | $-2.6M | $-2.0M |
| EPS | -0.26 | -0.26 | -0.25 | -0.22 | -0.22 |
| Gross Margin | 87.9% | 87.9% | 93.3% | 91.8% | 83.1% |
| Operating Margin | -475.4% | -475.4% | -312.3% | -333.9% | -427.0% |
| Net Margin | -826.2% | -826.2% | -279.2% | -284.7% | -360.0% |
| Balance Sheet | |||||
| Current Ratio | 10.34 | 10.34 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.7M | $-3.7M | $-3.5M | $-3.0M | $-434519.00 |
| Returns | |||||
| ROE | -118.7% | -118.7% | -43.1% | -26.8% | -15.5% |
| Valuation | |||||
| P/B | 35.85 | 35.85 | 116.87 | 141.09 | 92.03 |
| Growth & Yield | |||||
| Revenue Growth | -25.0% | -25.0% | 15.3% | 74.1% | — |
| EPS Growth | -3.1% | -3.1% | -13.1% | 0.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-46.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.25 → -0.26
Residual
-46.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.